Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis.

{"title":"Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis.","authors":"Insa Binte Anwar, Iqra Furqan Ahmed, Fariha Mahmood, Abdul Haseeb, Khabab Abbasher Hussien Mohamed Ahmed","doi":"10.1097/MS9.0000000000002839","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"87 1","pages":"20-23"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11918766/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Medicine and Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/MS9.0000000000002839","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}